MétaCan
Menu
Retour à la cohorte
Enregistrement W2318371367 · doi:10.1016/j.juro.2013.02.2690

1336 PCK3145 SUPPRESSES THE INVASIVE CAPABILITIES OF HUMAN PROSTATE CANCER CELLS INDUCED BY TRANSFORMING GROWTH FACTOR BETA

2013· article· en· W2318371367 sur OpenAlexaboutno aff
Qiang Zhang, Bob Lee, Xiao Lin, Zhihua Wang, Hélène Dulude, Chandra J. Panchal, Susan Slovin, James M. Kozlowski, Gregory Sivolapenko, T. M. Kuzel, Charles B. Brendler, William J. Catàlona, Yinglu Guo, Lin Chen, Ximing J. Yang, Borko Jovanovic, Chung Lee

Notice bibliographique

RevueThe Journal of Urology · 2013
Typearticle
Langueen
DomaineMedicine
ThématiqueProstate Cancer Treatment and Research
Établissements canadiensnon disponible
Organismes subventionnairesnon disponible
Mots-clésZhàngChinaBeijingProstate cancerMedicineLibrary scienceEnvironmental ethicsClassicsArt historyCancerHistoryPhilosophyInternal medicineComputer science

Résumé

récupéré en direct d'OpenAlex

You have accessJournal of UrologyProstate Cancer: Basic Research (VI)1 Apr 20131336 PCK3145 SUPPRESSES THE INVASIVE CAPABILITIES OF HUMAN PROSTATE CANCER CELLS INDUCED BY TRANSFORMING GROWTH FACTOR BETA Qiang Zhang, Bob Lee, Xiao Lin, Brian Helfand, Zhihua Wang, Helene Dulude, Chandra Panchal, Susan Slovin, James Kozlowski, Gregory Sivolapenko, Thimothy Michael Kuzel, Charles B Brendler, William J Catalona, Yinglu Guo, Lin Chen, Ximing J. Yang, Borko Jovanovic, and Chung Lee Qiang ZhangQiang Zhang Chicago, IL More articles by this author , Bob LeeBob Lee Chicago, IL More articles by this author , Xiao LinXiao Lin Fuzhou, Fujian, China, People's Republic of More articles by this author , Brian HelfandBrian Helfand Evanston, IL More articles by this author , Zhihua WangZhihua Wang Wuhan, Hubei, China, People's Republic of More articles by this author , Helene DuludeHelene Dulude Montreal, Canada More articles by this author , Chandra PanchalChandra Panchal Montreal, Canada More articles by this author , Susan SlovinSusan Slovin New York, New York More articles by this author , James KozlowskiJames Kozlowski Chicago, IL More articles by this author , Gregory SivolapenkoGregory Sivolapenko Patras, Greece More articles by this author , Thimothy Michael KuzelThimothy Michael Kuzel Chicago, IL More articles by this author , Charles B BrendlerCharles B Brendler Evanston, IL More articles by this author , William J CatalonaWilliam J Catalona Chicago, IL More articles by this author , Yinglu GuoYinglu Guo Beijing, China, People's Republic of More articles by this author , Lin ChenLin Chen Chicago, IL More articles by this author , Ximing J. YangXiming J. Yang Chicago, IL More articles by this author , Borko JovanovicBorko Jovanovic Chicago, IL More articles by this author , and Chung LeeChung Lee Chicago, IL More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2013.02.2690AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Metastases are responsible for mortality in prostate cancer (PCa). Previously, we reported that Transforming growth factor beta (TGF-β) induces epithelial-to-mesenchymal transition (EMT) and is associated with PCa metastases and biochemical recurrence. The human prostate secretory protein (PSP-94) is secreted by benign prostate cells and non-aggressive PCa. In this study, we explored the potential of migration inhibition for CaP by PCK3145 (a synthetic mimetic peptide of PSP-94) which may suppress TGF-β induced EMT. METHODS Human PCa cell lines PC-3, DU145 and PC-3M-LN4 and benign prostate cell RWPE1 were used for western blot and migration assays. All cells were treated with PCK3145 and/or TGF-β. For some experiments, cells expressing TGF-â domain negative type II receptor (Tβ RIIDN) were used. Four different treatment groups were assigned to each cell line: Group 1-no treatment (control); Group 2-treatment with TGF-β (10ng/mL) for 48 hours; Group 3-treatment with PCK3145 (100ug/mL) for 48 hours; and Group 4 – treatment with both TGF-β and PCK3145 for 48 hours. Immunohistochemical analyses were performed using primary antibodies against markers of the EMT including vimentin, laminin receptor (LR) and MMP-9. Cell invasion assays were performed in a 24-well matrigel transwell chamber (8-mm pore size). The invaded cells were counted with a light microscope under high magnification objective (100x) and were measured at OD560nm in a plate reader after treatment with the extraction solution. RESULTS Treatment of PCK3145 significantly decreases PCa migration (20 fold lower in PC-3 cells and 2 folds lower in DU145 cells; p<0.001). In addition, PCK3145 inhibits migration induced by TGF-β (30% inhibition for PC-3 cells, and 60% inhibition for DU145 cells; p<0.001). In consistent with the migration assay, analysis of cells exposed to both TGF-β and PCK3145, suppresses TGF-β induced vimentin expression, but not MMP-9 expression in DU145 and PC-3 cells. Treatment of TGF-β alone resulted in significant down-regulation of LR in both DU-145 and PC-3. However, LR was significantly up-regulated in in these cells by treatment of PCK3145 and by blockade of the TGF-β signaling through TβRIIDN. CONCLUSIONS We previously reported TGF-β induced EMT is associated with aggressive phenotypes of PCa. The present findings suggest that PCK3145 may inhibit TGF-β induced vimentin expression and invasion. Investigation of this peptide as an effective anti-tumor metastasis agent is warranted. © 2013 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 189Issue 4SApril 2013Page: e545-e546 Advertisement Copyright & Permissions© 2013 by American Urological Association Education and Research, Inc.MetricsAuthor Information Qiang Zhang Chicago, IL More articles by this author Bob Lee Chicago, IL More articles by this author Xiao Lin Fuzhou, Fujian, China, People's Republic of More articles by this author Brian Helfand Evanston, IL More articles by this author Zhihua Wang Wuhan, Hubei, China, People's Republic of More articles by this author Helene Dulude Montreal, Canada More articles by this author Chandra Panchal Montreal, Canada More articles by this author Susan Slovin New York, New York More articles by this author James Kozlowski Chicago, IL More articles by this author Gregory Sivolapenko Patras, Greece More articles by this author Thimothy Michael Kuzel Chicago, IL More articles by this author Charles B Brendler Evanston, IL More articles by this author William J Catalona Chicago, IL More articles by this author Yinglu Guo Beijing, China, People's Republic of More articles by this author Lin Chen Chicago, IL More articles by this author Ximing J. Yang Chicago, IL More articles by this author Borko Jovanovic Chicago, IL More articles by this author Chung Lee Chicago, IL More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,000
score de la tête « metaresearch » (Gemma)0,000
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Expérimental (laboratoire) · Signal consensuel: Expérimental (laboratoire)
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,013
Score d'incertitude au seuil0,043

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0000,000
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,000
Bibliométrie0,0000,000
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,001
Charge utile insuffisante (le modèle a refusé de juger)0,0130,003

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,029
Tête enseignante GPT0,300
Écart entre enseignants0,272 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeExpérimental (laboratoire)
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2013
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueThe Journal of UrologyMême sujetProstate Cancer Treatment and ResearchTravaux en français237 207